CrossRef Dysregulated Lipid Metabolism in Hepatocellular Carcinoma: Mechanisms and Therapeutic Strategies Yi Yi, Xi Liu, Xi Zhang, Yongsheng Li, Huakan Zhao MedComm Oncology .2026;[Epub] CrossRef Fibroblast- and Macrophage-Derived Thrombospondin-1 Orchestrates the Fibroinflammatory Niche in Metabolic Dysfunction-Associated Steatohepatitis-Induced Fibrosis Sung Woo Cho, Jung Hoon Cha, Deok Wha Seo, Mi Hyun Kwon, Kwon Yong Tak, Hee Sun Cho, Keungmo Yang, Seo Young Jung, SuHyun Hwangbo, Jae Yong Ryu, Si Hyun Bae, Pil Soo Sung Diabetes & Metabolism Journal .2026;[Epub] CrossRef Quantitative Systems Toxicology Model Predicts Obeticholic AcidAssociated Liver Injury in Metabolic DysfunctionAssociated Steatotic Liver Disease Abigail K
Many MCAS patients have impaired pathways for converting glutamate into calming GABA, leading to "glutamate excitotoxicity"which can manifest as severe anxiety, insomnia, heart palpitations, and brain fog
Patients typically receive tirzepatide as a once-weekly subcutaneous injection, with dosing titrated gradually from 2.5 mg to maintenance doses ranging from 5 mg to 15 mg depending on therapeutic response and tolerability
No FDA warning letter on Olympia
TNF, tumor necrosis factor